Physician profile
Steve Springer
NPI 1477538619
$6,254.47
in general payments reported to CMS, 2019-2025
38 companies · $865 in 2025
The $865 reported for 2025 was more than what 83% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $923 · 2020: $481 · 2021: $932 · 2022: $1,154 · 2023: $1,051 · 2024: $849 · 2025: $865.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,765.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,765.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $971.71 | 2019-2025 | Farxiga, Airsupra, Breztri |
| Abbvie INC. | $686.65 | 2021-2025 | Vraylar, Ubrelvy, Botox |
| Lilly USA, LLC | $608.52 | 2019-2025 | Mounjaro, Jardiance, Zepbound |
| Novo Nordisk INC | $451.44 | 2019-2025 | Ozempic, Rybelsus |
| Glaxosmithkline, LLC. | $435.83 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $392.56 | 2019-2025 | Jardiance, Synjardy |
| Dexcom, INC. | $258.75 | 2019-2025 | Dexcom G6 Transmitter |
| Novartis Pharmaceuticals Corporation | $245.18 | 2021-2025 | |
| Abbott Laboratories | $242.74 | 2021-2025 | Freestyle Libre 3 |
| Pfizer INC. | $205.86 | 2019-2025 | |
| Phathom Pharmaceuticals, INC. | $177.55 | 2023-2025 | Voquezna |
| Exact Sciences Corporation | $173.59 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Takeda Pharmaceuticals U.S.A., INC. | $132.72 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $130.47 | 2021-2025 | |
| Sanofi-Aventis U.S. LLC | $126.41 | 2019-2021 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steve Springer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.